As of June 27, 2019 the number of shares outstandi
Post# of 30027
(Total Views: 735)
Posted On: 07/01/2019 7:22:35 PM
.jpg)
As of June 27, 2019 the number of shares outstanding of our Common Stock was: 258,051,454
Number of shares in the Public Float6: 125,086,151 as of date: 06/13/2019
Total number of shareholders of record: 205 as of date: 06/13/2019
Behold the history of dilution (goes beyond 2019)!!!! Since September 2017, 180M shares have been diluting us for services, settlements, conversions etc. Most recently...
1/8/2019 New 12,250,000 New Common Services Restricted
2/5/2019 New 2,000,000 Common $0.028 Services Restricted
5/15/2019 Cancel 55,000 Common retire
5/24/2019 New 1,761,494 Common $0.0114 Debt Conversion Unrestricted
5/31/2019 New 4,000,000 Common $0.023 Services Restricted
6/4/2019 New 2,777,778 $0.009 Debt Conversion Unrestricted
6/10/2019 Cancel 1195 Series I $1,000 No GHS Exchange to Debt
6/11/2019 New 1,000,000 Common $0.020 Services Restricted
The common conversions are to unidentified parties. The Series I is of course to GHS. This new debt, along with all other debt (Total approximately $18M) from the Legacy Convertibles or Toxics or whatever you want to call (Lincoln Park, Delafield, Anson, Dominion,, KDL Holdings, Gemini, BMI, Greentree, Roger Challen, Vivacitas, International Infusion) is totaled and described to be converted through Reg A with an expiration of 3/31/2020. Not exactly an indefinite like the previous letter to shareholders said.
If I'm reading this correctly, GC seems to have, at some point, bought out 64% of the series H, 87% of the series E, 100% of the series F. This is important because as of this filing, the only preferred class shares that exist are B,E,F, H. I thought Geral already owned all the B, but that isn't listed.
Number of shares in the Public Float6: 125,086,151 as of date: 06/13/2019
Total number of shareholders of record: 205 as of date: 06/13/2019
Behold the history of dilution (goes beyond 2019)!!!! Since September 2017, 180M shares have been diluting us for services, settlements, conversions etc. Most recently...
1/8/2019 New 12,250,000 New Common Services Restricted
2/5/2019 New 2,000,000 Common $0.028 Services Restricted
5/15/2019 Cancel 55,000 Common retire
5/24/2019 New 1,761,494 Common $0.0114 Debt Conversion Unrestricted
5/31/2019 New 4,000,000 Common $0.023 Services Restricted
6/4/2019 New 2,777,778 $0.009 Debt Conversion Unrestricted
6/10/2019 Cancel 1195 Series I $1,000 No GHS Exchange to Debt
6/11/2019 New 1,000,000 Common $0.020 Services Restricted
The common conversions are to unidentified parties. The Series I is of course to GHS. This new debt, along with all other debt (Total approximately $18M) from the Legacy Convertibles or Toxics or whatever you want to call (Lincoln Park, Delafield, Anson, Dominion,, KDL Holdings, Gemini, BMI, Greentree, Roger Challen, Vivacitas, International Infusion) is totaled and described to be converted through Reg A with an expiration of 3/31/2020. Not exactly an indefinite like the previous letter to shareholders said.
If I'm reading this correctly, GC seems to have, at some point, bought out 64% of the series H, 87% of the series E, 100% of the series F. This is important because as of this filing, the only preferred class shares that exist are B,E,F, H. I thought Geral already owned all the B, but that isn't listed.
(4)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼